278 related articles for article (PubMed ID: 23775973)
1. Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.
Moy B; Bradbury AR; Helft PR; Egleston BL; Sheikh-Salah M; Peppercorn J
J Clin Oncol; 2013 Jul; 31(21):2678-84. PubMed ID: 23775973
[TBL] [Abstract][Full Text] [Related]
2. Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research.
Hampson LA; Joffe S; Fowler R; Verter J; Emanuel EJ
J Clin Oncol; 2007 Aug; 25(24):3609-14. PubMed ID: 17704409
[TBL] [Abstract][Full Text] [Related]
3. Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.
Saleh RR; Majeed H; Tibau A; Booth CM; Amir E
Cancer; 2019 Nov; 125(22):4069-4075. PubMed ID: 31355923
[TBL] [Abstract][Full Text] [Related]
4. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
[TBL] [Abstract][Full Text] [Related]
5. Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019.
Desai AP; Chengappa M; Go RS; Poonacha TK
Cancer; 2020 Aug; 126(16):3742-3749. PubMed ID: 32497271
[TBL] [Abstract][Full Text] [Related]
6. Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?
Sharma S; Booth CM; Eisenhauer EA; Gyawali B
J Natl Compr Canc Netw; 2021 Jul; 19(11):1258-1263. PubMed ID: 34325401
[TBL] [Abstract][Full Text] [Related]
7. Financial conflicts of interest in economic analyses in oncology.
Jang S; Chae YK; Majhail NS
Am J Clin Oncol; 2011 Oct; 34(5):524-8. PubMed ID: 21441858
[TBL] [Abstract][Full Text] [Related]
8. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.
Mitchell AP; Basch EM; Dusetzina SB
JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170
[TBL] [Abstract][Full Text] [Related]
9. Financial disclosures of scientific papers presented at the 2003 RSNA Annual Meeting: association with reporting of non-Food and Drug Administration-approved uses of industry products.
Brown SD; Daly JC; Kalish LA; McDaniel SA
Radiology; 2006 Jun; 239(3):849-55. PubMed ID: 16641343
[TBL] [Abstract][Full Text] [Related]
10. The contribution of limited-resource countries to the American Society of Clinical Oncology annual meetings.
Masmoudi A
Int J Clin Oncol; 2009 Oct; 14(5):442-6. PubMed ID: 19856054
[TBL] [Abstract][Full Text] [Related]
11. Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines.
Lu Y; Jones DJ; Sharara N; Kaltenbach T; Laine L; McQuaid K; Soetikno R; Subramanian V; Barkun A
PLoS One; 2017; 12(8):e0182856. PubMed ID: 28841650
[TBL] [Abstract][Full Text] [Related]
12. Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015.
Yoo SK; Ahmed AA; Ileto J; Zaorsky NG; Deville C; Holliday EB; Wilson LD; Jagsi R; Thomas CR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):280-285. PubMed ID: 28366578
[TBL] [Abstract][Full Text] [Related]
13. Financial conflicts of interest of OncoAlert: An informal oncology professional network.
Powell K; Kakkilaya A; Haslam A; Prasad V
J Cancer Policy; 2022 Dec; 34():100369. PubMed ID: 36396090
[TBL] [Abstract][Full Text] [Related]
14. A new method for scoring financial conflicts of interest.
Maharaj SV
Int J Occup Environ Health; 2015; 21(1):49-52. PubMed ID: 25633929
[TBL] [Abstract][Full Text] [Related]
15. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
[TBL] [Abstract][Full Text] [Related]
16. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.
Tibau A; Bedard PL; Srikanthan A; Ethier JL; Vera-Badillo FE; Templeton AJ; Ocaña A; Seruga B; Barnadas A; Amir E
J Clin Oncol; 2015 Jan; 33(1):100-6. PubMed ID: 25385736
[TBL] [Abstract][Full Text] [Related]
17. The geography of clinical cancer research: analysis of abstracts presented at the American Society of Clinical Oncology Annual Meetings.
Saad ED; Mangabeira A; Masson AL; Prisco FE
Ann Oncol; 2010 Mar; 21(3):627-632. PubMed ID: 19717537
[TBL] [Abstract][Full Text] [Related]
18. Financial Relationships With Industry of Editorial Board Members of the Three Journals of the American Society for Radiation Oncology.
Verma V
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):286-291. PubMed ID: 28871971
[TBL] [Abstract][Full Text] [Related]
19. Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography.
Combs T; Tritz D; Ivy H; von Borstel D; Horn J; Vassar M
J Am Coll Radiol; 2019 Nov; 16(11):1598-1603. PubMed ID: 31152689
[TBL] [Abstract][Full Text] [Related]
20. Financial Conflicts of Interest, Disclosure, and Academic Discipline.
Bruton SV; Sacco DF; Didlake R
J Empir Res Hum Res Ethics; 2016 Apr; 11(2):165-9. PubMed ID: 27009304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
